Selling, page-36

First 36 Last

Share
Profile

Follow
Merchant2000

20,920 Posts.

875

14/06/19

08:24

Post #: 39053189
Share

Originally posted by qqqqqqqqq: ↑

Valuation: Increased to $64–111m
We increase our indicative valuation range to $64–111m or $10.31–17.82 per ADR (vs $63–105m, $10.51–17.57 per ADR), under either post-Phase III approval or accelerated approval scenarios for GDC-0084. We have rolled forward our model and have made adjustment for the sale of the Noxopharm shareholding for $1.8m (vs our previous valuation of $2.7m). We estimate that cash of $4.1m at 31 December 2018 plus the Noxopharm sale proceeds will fund activity into H219, by which time preliminary data from the GDC-0084 Phase IIa are expected to have read out. We estimate that Kazia will need additional funds in the order of $11-15m to fully fund the GDC-0084 Phase IIb study.

IMO full increased valuation of KZA $64m - $111m based on post phase 111 approval or accelerated approval of GDC0084 - which has to be years away from now at best

imo
$23m market cap at present is far from cheap based on the valuations above - hence no conspiracy or manipulation theories or Hopper selling tiny 150k shares in one month

The licence deal - agreements imo is the key here

Was this a good deal for KZA based on above valuations. etc.....
Expand
Kazia Therapeutics Ltd
NASDAQ: KZIA
2.73USD−0.12(4.21%)
13 Jun, 4:00 pm GMT-4 ·Disclaimer
1 day
5 days
1 month
6 months
YTD
1 year
5 years
Max
2.73 USD‎14:20
2.62.72.82.93.0Previous
close
2.85

10:00 am12:00 pm1:00 pm2:00 pm3:00 pm4:00 pm
Open 2.67
1 High 2.93
2 Low 2.64
3 Mkt cap 169.72M
4 P/E ratio -
Div yield -
1 Prev close 2.85
2 52-wk high 5.40
3 52-wk low 2.04

KZA Price at posting: 37.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Nine's staff strike as Paris Olympic coverage begins

ASX Market Open: ASX200 to rise for Friday session | July 26

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

	Open	2.67
1	High	2.93
2	Low	2.64
3	Mkt cap	169.72M
4	P/E ratio	-

	Div yield	-
1	Prev close	2.85
2	52-wk high	5.40
3	52-wk low	2.04

There are more pages in this discussion • 143 more messages in this thread...

First 36 Last

Add KZA (ASX) to my watchlist

Selling, page-36

Top Stories

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Nine's staff strike as Paris Olympic coverage begins

ASX Market Open: ASX200 to rise for Friday session | July 26

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Featured News